96 results
Page 2 of 5
424B5
8nm0qj5
8 Jan 21
Prospectus supplement for primary offering
2:17pm
S-3ASR
toaskgykkwbb893nwxw
5 Jan 21
Automatic shelf registration
4:05pm
8-K
EX-99.1
s7r 2m8ci
27 Oct 20
NeoGenomics Reports Revenue Growth of 20% to Record $125 Million
7:59am
8-K
EX-99.1
uz8x0
28 Jul 20
NeoGenomics Reports Revenue of $87 Million
8:18am
424B5
sz8 niynscylzmi5pj
1 May 20
Prospectus supplement for primary offering
5:02pm
S-3ASR
x9gjfj7p1 zlycj
29 Apr 20
Automatic shelf registration
5:18pm
8-K
EX-2.1
6um0 qetb1e
13 Jan 20
NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million
4:50pm
8-K
EX-10.2
61locuj
8 Aug 19
Departure of Directors or Certain Officers
7:16am
8-K
EX-10.1
g1w8tiu
28 Jun 19
NeoGenomics Announces New $250 Million Credit Agreement
4:06pm
8-K
EX-1.1
e1wl3
12 Dec 18
NeoGenomics Announces Pricing on Secondary Offering of
4:18pm
8-K
EX-99.1
1z0ptt
10 Dec 18
Completion of Acquisition or Disposition of Assets
5:14pm
8-K
EX-2.1
ger9vkaioxe359 gj
26 Oct 18
Entry into a Material Definitive Agreement
5:23pm